For a patient considering a major surgery abroad, the most daunting step is often not the procedure itself, but the opaque journey to find it. The search typically begins with informal agents, unverified online forums, and a paralyzing lack of trustworthy data on hospital quality, surgeon credentials, or final costs. CureMeAbroad, a Pune-based startup founded in 2025, is betting that an AI-powered marketplace can bring clarity to this fragmented and high-stakes process [Economic Times Startup, April 2026].
Co-founders Aditya Oza and Mikhail Bohra are cousins who launched the company after recognizing the inefficiencies in cross-border healthcare coordination [Hindustan Times, March 2026]. Their platform aims to replace a network of informal intermediaries with a verified directory, allowing patients to discover, compare, and book treatments at accredited hospitals overseas. The company has raised $1.7 million across two pre-seed rounds to build out its network and technology, with backing from notable angels including Unacademy co-founder Roman Saini and SteerX Ventures [Digital Health News, October 2026].
The bet on verified clarity
CureMeAbroad's core proposition is reducing the complexity and inherent risk of seeking medical care in another country. The platform's reported features are designed to address specific patient pain points: verifying providers against international accreditations like JCI, offering AI-based clinical matching, generating treatment-cost estimates, and providing end-to-end booking and support [Economic Times Startup, April 2026]. This stands in contrast to simpler listing services, positioning the company as a navigator rather than just a directory.
The company's reported traction centers on building a credible network. As of April 2026, it claimed a network of more than 380 hospitals across key medical tourism destinations including India, Mexico, Turkey, Thailand, and Georgia [Economic Times Entrepreneur, April 2026]. Other reports cite a broader directory of over 6,000 hospitals across 47 countries, though the depth of partnership in that larger set is unclear [Travel And Tour World, Unknown]. The focus appears to be on cultivating deeper relationships with several hundred accredited institutions to ensure quality and reliable pricing.
Funding a global hospital network
The company's $1.7 million in pre-seed capital was raised in two tranches, signaling early investor confidence in its asset-light, marketplace model. The first $600,000 round in April 2026 was led by a syndicate of angel investors with roots in Indian tech and consumer startups [Economic Times Startup, April 2026]. A larger $1.1 million round followed in October 2026, led by SteerX Ventures with participation from existing investor AIRA Buildon [Digital Health News, October 2026].
April 2026 | 0.6 | M USD
October 2026 | 1.1 | M USD
The proceeds are earmarked for expanding the hospital network, growing the technology team, and acquiring patients from source markets like the United States and Australia [Digital Health News, October 2026]. The founders had also previously invested their own capital, reportedly ₹3 crore, to bootstrap the initial operation [Hindustan Times, March 2026].
Building credibility in a sensitive field
Given the life-altering nature of its service, CureMeAbroad has actively pursued external validations to build trust. In July 2026, the company became a signatory to the United Nations Global Compact, a voluntary initiative based on universal sustainability principles [Express Healthcare, July 2026]. It has also received a Medical Travel Facilitator Certification from Global Healthcare Accreditation, a credential aimed at standardizing patient care and business practices in medical tourism [entrackr.com, Unknown].
These steps, alongside partnerships announced with clinics like Asia Cosmetics and Dr Brenda’s Clinic, are part of a strategy to institutionalize a service sector historically dominated by individual brokers [Express Healthcare, July 2026]. For investors like Roman Saini and Kunal Gupta (co-founder and CEO of EMotorad), the bet is that professionalization and technology can capture a significant share of a growing global market [Financial Express, April 2026].
The competitive and operational landscape
The market for facilitating cross-border care is not empty. Established players like Bookimed, PlacidWay, and Medical Departures have been operating for years, offering similar services of connecting patients with international hospitals. CureMeAbroad's differentiation hinges on its emphasis on AI-driven matching and a stated deeper focus on verification and post-booking support. However, scaling a two-sided marketplace presents well-documented challenges.
- Network density. The platform's utility depends on having a sufficient depth of high-quality hospital partners in each treatment specialty and destination. A directory of thousands is less valuable if only a fraction offer bookable, transparent packages.
- Patient acquisition. Attracting patients requires significant marketing spend and trust-building in an industry where a single negative outcome can be devastating to reputation. The company's reported quarterly revenue of $500,000, leading to a $2.4 million annualized run rate as of March 2026, suggests early transaction volume, but these are company-reported figures [Hindustan Times, March 2026].
- Coordination complexity. Facilitating international care involves logistics far beyond a simple booking: travel, lodging, interpreter services, and follow-up care. Managing this experience consistently is operationally intensive.
The company is hiring for roles in partnerships, finance, and operations, indicating a focus on strengthening these core marketplace functions [Third-party listings, August 2026].
A new standard for a stressful journey
The patient population CureMeAbroad serves is diverse, but united by a common need: access to quality, affordable medical care that is unavailable or prohibitively expensive at home. This includes individuals seeking elective procedures like cosmetic surgery, as well as those needing critical treatments such as orthopedic surgeries, cardiac care, or oncology. The emotional and financial stakes for these patients are exceptionally high.
The standard of care in medical tourism today is a patchwork. It often relies on word-of-mouth referrals, opaque pricing negotiated through agents, and a leap of faith regarding hospital standards. Patients can find themselves navigating language barriers, unclear payment structures, and uncertain outcomes with limited recourse. CureMeAbroad's attempt to bring a layer of technology and verification to this process is less about disrupting a high-tech industry and more about introducing basic reliability and transparency to a deeply human and stressful journey. The next twelve months will test whether its model of a verified, AI-assisted marketplace can achieve the scale and trust required to become a default choice for patients looking beyond their borders for care.
Sources
- [Digital Health News, October 2026] CureMeAbroad Raises $1.1 Mn in Pre-Seed Round Led by SteerX Ventures | https://www.digitalhealthnews.com/curemeabroad-raises-1-1-mn-in-pre-seed-round-led-by-steerx-ventures
- [Economic Times Startup, April 2026] Curemeabroad secures 600k pre seed funding to rework medical tourism | https://startup.economictimes.indiatimes.com/news/funding-deals/curemeabroad-secures-600k-pre-seed-funding-to-rework-medical-tourism/130442881
- [Economic Times Entrepreneur, April 2026] CureMeAbroad bags $600,000 pre-seed funding led by angel investors | https://entrepreneur.economictimes.indiatimes.com/news/funding/curemeabroad-secures-600000-in-pre-seed-funding-to-transform-medical-tourism/130419503
- [Hindustan Times, March 2026] Connecting patients to care without borders | https://www.hindustantimes.com/cities/pune-news/connecting-patients-to-care-without-borders-101774637315868.html
- [Express Healthcare, July 2026] CureMeAbroad signs MoUs with Asia Cosmetics and Dr Brenda’s Clinic | https://www.expresshealthcare.in/amp/news/curemeabroad-signs-mous-with-asia-cosmetics-and-dr-brendas-clinic/454537/
- [Financial Express, April 2026] CureMeAbroad raises $ 600000 in pre-seed round | https://www.financialexpress.com/business/start-ups/curemeabroad-raises-600000-in-pre-seed-round-startup-aiming-to-simplify-medical-tourism-gets-backing-from-roman-saini/4214478/
- [Travel And Tour World, Unknown] The Future of Cross-Border Care: How CureMeAbroad’s $600K Seed Funding is Humanizing Medical Tourism Through AI | https://www.travelandtourworld.com/news/article/the-future-of-cross-border-care-how-curemeabroads-600k-seed-funding-is-humanizing-medical-tourism-through-ai/